ATF4 and Parkinson disease: The brain biopsy tissues from PD patients also exhibit elevated levels of ATF-4 immunostaining in the neuromelanin-positive neurons suggesting that ATF-4 expression is affected by the mean duration of the PD; the longer the progression the higher the ATF-4 expression levels [160].